네오켄바이오
1 known investors
NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.
Investors · 1
Frequently asked questions
- What does 네오켄바이오 do?
- NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.
- Who are 네오켄바이오's investors?
- 네오켄바이오's investors include Hyundai Venture Investment Corporation.